Figure 2.
The morphology of esophageal cancer cells treated by Armillaridin. Cells were treated with a vehicle as control (left) or Armillaridin 10 μM for 3 days (right). (a) CE81T/VGH squamous carcinoma cells. (b) BE-3 adenocarcinoma cells.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.